Your browser doesn't support javascript.
loading
SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot.
Achtnichts, Lutz; Ovchinnikov, Arkady; Jakopp, Barbara; Oberle, Michael; Nedeltchev, Krassen; Fux, Christoph Andreas; Sellner, Johann; Findling, Oliver.
Affiliation
  • Achtnichts L; Department of Neurology, Aarau Cantonal Hospital, 5000 Aarau, Switzerland.
  • Ovchinnikov A; Department of Neurology, Aarau Cantonal Hospital, 5000 Aarau, Switzerland.
  • Jakopp B; Department of Infectious Diseases and Hospital Infection Prevention, Aarau Cantonal Hospital, 5000 Aarau, Switzerland.
  • Oberle M; Institute for Laboratory Medicine, Aarau Cantonal Hospital, 5000 Aarau, Switzerland.
  • Nedeltchev K; Department of Neurology, Aarau Cantonal Hospital, 5000 Aarau, Switzerland.
  • Fux CA; Department of Neurology, University of Bern, 3012 Bern, Switzerland.
  • Sellner J; Department of Infectious Diseases and Hospital Infection Prevention, Aarau Cantonal Hospital, 5000 Aarau, Switzerland.
  • Findling O; Department of Neurology, Landesklinikum Mistelbach-Gänserndorf, 2130 Mistelbach, Austria.
Vaccines (Basel) ; 10(2)2022 Feb 21.
Article in En | MEDLINE | ID: mdl-35214799
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Vaccines (Basel) Year: 2022 Document type: Article Affiliation country: Switzerland Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Vaccines (Basel) Year: 2022 Document type: Article Affiliation country: Switzerland Country of publication: Switzerland